Advisor Resource Council’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,425	Closed	-$2.24M	–	385
2025 Q1	$2.24M	Buy	+22,425	New	+$2.24M	0.18%	139
2024 Q1	–	Sell	-2,804	Closed	-$200K	–	375
2023 Q4	$200K	Buy	+2,804	New	+$200K	0.02%	459